Hyaluronic acid–conjugated silica nanoparticles for breast cancer therapy

References

• Ma, J.; Jemal, A. Breast cancer statistics. Mayo Clinic Proceedings, 1980, 55, 1–18.
   Google Scholar
• Abbad, S.; Wang, C.; Waddad, A. Y.; Lv, H.; Zhou, J. Preparation, in vitro and in vivo evaluation of polymeric nanoparticles based on hyaluronic acid-poly (butyl cyanoacrylate) and D-alpha-tocopheryl polyethylene glycol 1000 succinate for tumor-targeted delivery of morin hydrate. Int. J. Nanomed. 2015, 10, 305.
   PubMed Web of Science ®Google Scholar
• Wang, C.; Li, M.; Yang, T.; Ding, X.; Bao, X.; Ding, Y.; Xiong, H.; Wu, Y.; Wang, W.; Zhou, J. A self-assembled system for tumor-targeted co-delivery of drug and gene. Mater. Sci. Eng. C. 2015, 56, 280–285.
   PubMed Web of Science ®Google Scholar
• Cho, K.; Wang, X.; Nie, S.; Shin, D. M. Therapeutic nanoparticles for drug delivery in cancer. Clin. Cancer Res. 2008, 14, 1310–1316.
   PubMed Web of Science ®Google Scholar
• Neuberger, T.; Schöpf, B.; Hofmann, H.; Hofmann, M.; Von Rechenberg, B. Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system. J. Magn. Magn. Mater. 2005, 293, 483–496.
   Web of Science ®Google Scholar
• Sun, X.; Wang, W.; Huang, J.; Lai, H.; Guo, C.; Wang, C. A biomimic reconstituted high density lipoprotein nanosystem for enhanced vegf gene therapy of myocardial ischemia. J. Nanomater. 2015, 2015, 174.
   Google Scholar
• Hao, S.; Yan, Y.; Ren, X.; Xu, Y.; Chen, L.; Zhang, H. Candesartan-graft-polyethyleneimine cationic micelles for effective co-delivery of drug and gene in anti-angiogenic lung cancer therapy. Biotechnol Bioproc E. 2015, 20, 550–560.
   Web of Science ®Google Scholar
• Li, M.; Li, Y.; Huang, X.; Lu, X. Captopril-polyethyleneimine conjugate modified gold nanoparticles for co-delivery of drug and gene in anti-angiogenesis breast cancer therapy. J. Biomater. Sci., Polym. Ed. 2015, 26, 1–15.
   Web of Science ®Google Scholar
• Liu, E.; Zhou, Y.; Liu, Z.; Li, J.; Zhang, D.; Chen, J.; Cai, Z. Cisplatin loaded hyaluronic acid modified TiO 2 nanoparticles for neoadjuvant chemotherapy of ovarian cancer. J. Nanomater. 2015, 16(1), 275.
   Google Scholar
• Lu, H.; Zhang, H.; Zhang, D.; Lu, H.; Ma, D. A biocompatible reconstituted high-density lipoprotein nano-system as a probe for lung cancer detection. Med. Sci. Monitor. 2015, 21, 2726–2733.
   PubMed Web of Science ®Google Scholar
• Wu, H.; Zhao, Y.; Mu, X.; Wu, H.; Chen, L.; Liu, W.; Mu, Y.; Liu, J.; Wei, X. A silica–polymer composite nano system for tumor-targeted imaging and p53 gene therapy of lung cancer. J. Biomater. Sci., Polym. Ed. 2015, 26, 384–400.
   PubMed Web of Science ®Google Scholar
• Ouyang, Q.; Duan, Z.; Jiao, G.; Lei, J. A biomimic reconstituted high-density-lipoprotein-based drug and p53 gene co-delivery system for effective antiangiogenesis therapy of bladder cancer. Nanoscale Res. Lett. 2015, 10, 965.
   PubMed Web of Science ®Google Scholar
• Yu, K.; Wu, S.; Li, H. A chitosan-graft-PEI-eprosartan conjugate for cardiomyocyte-targeted VEGF plasmid delivery in myocardial ischemia gene therapy. J. Exp. Nanosci. 2015, 1, 1–16.
   Web of Science ®Google Scholar
• Culty, M.; Shizari, M.; Thompson, E. W.; Underhill, C. B. Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: Correlation with invasive potential. J. Cellular Physiol. 1994, 160, 275–286.
   PubMed Web of Science ®Google Scholar
• Kaufmann, M.; von Minckwitz, G.; Heider, K.; Ponta, H.; Herrlich, P.; Sinn, H. CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet. 1995, 345, 615–619.
   PubMed Web of Science ®Google Scholar
• Auvinen, P.; Tammi, R.; Parkkinen, J.; Tammi, M.; Ågren, U.; Johansson, R.; Hirvikoski, P.; Eskelinen, M.; Kosma, V. M. Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am. J. Pathol. 2000, 156, 529–536.
   PubMed Web of Science ®Google Scholar
• Götte, M.; Yip, G. W. Heparanase, hyaluronan, and CD44 in cancers: A breast carcinoma perspective. Cancer Res. 2006, 66, 10233–10237.
   PubMed Web of Science ®Google Scholar
• Tanabe, K. K.; Nishi, T.; Saya, H. Novel variants of CD44 arising from alternative splicing: Changes in the CD44 alternative splicing pattern of MCF‐7 breast carcinoma cells treated with hyaluronidase. Mol. Carcinogenesis. 1993, 7, 212–220.
   PubMed Web of Science ®Google Scholar